Nadine McGrath is a journalist with a focus on national news in Australia. She writes for various publications including Stockhead, NXTmine, Cairns Post, and North Queensland News. Nadine's articles cover a range of topics including investment tips, stock market analysis, and emerging trends in various industries.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Australia (National)
Nadine's focus on investment analysis and press releases indicates that she is likely to respond well to pitches offering unique insights into stock market trends, particularly within the healthcare and pharmaceutical industries. She may also be interested in receiving data-driven analyses or exclusive information related to ASX-listed companies.
Given her coverage of sales & marketing themes, Nadine might also appreciate pitches that provide in-depth analysis of marketing strategies or sales performance within the sectors she covers.
Since her geographic focus is national (Australia), sources with a deep understanding of this market and its specific dynamics would be most relevant for outreach.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Nadine McGrath
Organisations increasingly working to stay ahead of scammers and protect identity and funds of their customers
Australia, like much of the Western world, is becoming an increasingly cashless society, with most of our financial transactions completed digitally.
By: Nadine McGrath
Imricor has two upcoming pivotal trials and is looking to transform cardiac ablation procedures
By: Nadine McGrath
ASX health stock rise in past five days along with broader markets Wound care company Polynovo achieves its first ever $10m+ revenue month in April
From laboratories and hospitals to company boardrooms, there is much to keep an eye on in the ASX biotech sector for the remainder of 2024, according to fund managers and analysts.
By: Nadine McGrath
Organisations increasingly strive to stay ahead of scammers and safeguard identity and funds of customers
The remainder of 2024 looks like being a busy for the ASX biotech sector, with analysts and fund managers saying there are plenty of upcoming catalysts and company-specific developments on the horizon.
By: Nadine McGrath
Optiscan enters know-how agreement with world-renowned Mayo Clinic for major pathology breakthrough
As the move away from cash builds pace, digital financial services providers are beefing up security as a buffer against hackers and scammers.
By: Nadine Mcgrath
Several ASX listed funds and companies offer exposure to the burgeoning private credit market including VanEck and Pengana Capital.
(833) 317-6278 
